Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1Phase 1/2 1

Status

Completed 18Unknown 14Active not recruiting 4Withdrawn 2Terminated 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Hodgkin Disease 3Prostatic Neoplasms 2Leukemia, Biphenotypic, Acute 2Down Syndrome 2Burkitt Lymphoma 2Urogenital Neoplasms 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Non-Hodgkin 1Leukemia 1Asthma 1

Interventions

Cyclophosphamide 26Rituximab 22Biopsy 17Specimen Handling 16Prednisone 14Magnetic Resonance Spectroscopy 14Doxorubicin 14fludarabine 12Vincristine 12fludarabine phosphate 9Etoposide 7Bendamustine Hydrochloride 7Tacrolimus 6Nuclear Medicine Department, Hospital 6Melphalan 6trametinib 5acalabrutinib 5X-Rays 5Whole-Body Irradiation 5Radiotherapy 5Mycophenolic Acid 5Crizotinib 5pembrolizumab 4copanlisib 4Prednisolone 4Mesna 4Lenalidomide 4Dexamethasone 4Cytarabine 4Busulfan 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Lymphoma × Prednisolone × Clear all
NCT04546620 2026-04-30

REMoDL-A

University Hospital Southampton NHS Foundation Trust

Phase 2 Active not recruiting
453 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT03117751 2025-12-05

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

St. Jude Children's Research Hospital

Phase 2/3 Active not recruiting
790 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05406401 2024-10-15

waveLINE-007

Merck Sharp & Dohme LLC

Phase 2 Active not recruiting
60 enrolled
Lymphoid

Lymphoma

NCT02889523 2024-10-09

Epi-RCHOP

The Lymphoma Academic Research Organisation

Phase 1/2 Active not recruiting
214 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡